Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.95
Delayed Data
As of Jul 02
 +1.12 / +19.21%
Today’s Change
3.71
Today|||52-Week Range
10.44
+52.41%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close5.83
Today’s open5.80
Day’s range5.80 - 7.32
Volume573,190
Average volume (3 months)181,124
Market cap$80.3M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.38

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...+0.05+1.02%
CRBPCorbus Pharmaceutica...-0.02-0.65%
IMMYImprimis Pharmaceuti...+0.08+0.98%
MSTXMast Therapeutics In...-0.01-2.04%
Data as of 4:01pm ET, 07/02/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers